Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
/in Glioblastoma, International PublicationsDendritic cell-based active specific immunotherapy for malignant glioma
/in Glioblastoma, International PublicationsUse of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
/in Glioblastoma, International PublicationsAntitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
/in Glioblastoma, International PublicationsPersistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
/in Glioblastoma, International Publications, IOZK VeröffentlichungenAntigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
/in Glioblastoma, International Publicationsp53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
/in Glioblastoma, International Publications, Newcastle Disease VirusDendritic cell vaccination in patients with malignant gliomas: current status and future directions
/in Glioblastoma, International Publications, IOZK Veröffentlichungen
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer